DK1171108T3 - Kombinationspræparat til behandling af malaria - Google Patents
Kombinationspræparat til behandling af malariaInfo
- Publication number
- DK1171108T3 DK1171108T3 DK00921746T DK00921746T DK1171108T3 DK 1171108 T3 DK1171108 T3 DK 1171108T3 DK 00921746 T DK00921746 T DK 00921746T DK 00921746 T DK00921746 T DK 00921746T DK 1171108 T3 DK1171108 T3 DK 1171108T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- malaria
- combination preparation
- proguanil
- primaquine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12867299P | 1999-04-09 | 1999-04-09 | |
PCT/US2000/009091 WO2000061133A1 (en) | 1999-04-09 | 2000-04-05 | Combination preparation for treating malaria |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1171108T3 true DK1171108T3 (da) | 2003-10-06 |
Family
ID=22436426
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00921746T DK1171108T3 (da) | 1999-04-09 | 2000-04-05 | Kombinationspræparat til behandling af malaria |
Country Status (24)
Country | Link |
---|---|
US (1) | US6413993B1 (hu) |
EP (1) | EP1171108B1 (hu) |
JP (1) | JP2002541196A (hu) |
KR (1) | KR100613805B1 (hu) |
CN (1) | CN1152676C (hu) |
AT (1) | ATE241971T1 (hu) |
AU (1) | AU758167B2 (hu) |
BR (1) | BR0009676A (hu) |
CA (1) | CA2369089A1 (hu) |
CZ (1) | CZ294903B6 (hu) |
DE (1) | DE60003175T2 (hu) |
DK (1) | DK1171108T3 (hu) |
ES (1) | ES2199817T3 (hu) |
HK (1) | HK1041638A1 (hu) |
HU (1) | HUP0200842A3 (hu) |
IL (2) | IL145609A0 (hu) |
MX (1) | MXPA01010125A (hu) |
NO (1) | NO20014806L (hu) |
NZ (1) | NZ514353A (hu) |
PL (1) | PL350987A1 (hu) |
PT (1) | PT1171108E (hu) |
TR (1) | TR200102843T2 (hu) |
WO (1) | WO2000061133A1 (hu) |
ZA (1) | ZA200108254B (hu) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9224739D0 (en) * | 1992-11-26 | 1993-01-13 | Wellcome Found | Medicaments |
WO2009137100A2 (en) * | 2008-05-09 | 2009-11-12 | Tolmar, Inc. | Proguanil to treat skin/mucosal diseases |
US20110206770A1 (en) * | 2008-07-25 | 2011-08-25 | Alphapharm Pty. Ltd. | Atovaquone with a particle size diameter range (d90) of greater than 3 microns to about 10 microns |
WO2011021230A2 (en) * | 2009-08-20 | 2011-02-24 | Ipca Laboratories Limited | Novel complex for treatment and/or prophylaxis of parasitic infections |
EP3415147A4 (en) * | 2016-02-12 | 2019-07-10 | Kao Corporation | MELANIN DEGRADATION INHIBITOR |
AU2017338924B2 (en) * | 2016-10-05 | 2023-02-16 | Titan Pharmaceuticals, Inc. | Implantable devices for drug delivery with reduced burst release |
US20200155481A1 (en) * | 2017-05-03 | 2020-05-21 | The Johns Hopkins University | Intramuscular atovaquone for malaria prophylaxis |
CN107737108B (zh) * | 2017-12-17 | 2018-06-26 | 姚蕾 | 一种治疗心肌梗死后心室重塑的口服药物组合物 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9224739D0 (en) * | 1992-11-26 | 1993-01-13 | Wellcome Found | Medicaments |
JPH0873355A (ja) * | 1994-09-02 | 1996-03-19 | Mitsui Toatsu Chem Inc | 抗マラリア薬耐性克服剤 |
-
2000
- 2000-04-05 AU AU42022/00A patent/AU758167B2/en not_active Ceased
- 2000-04-05 IL IL14560900A patent/IL145609A0/xx active IP Right Grant
- 2000-04-05 CZ CZ20013646A patent/CZ294903B6/cs not_active IP Right Cessation
- 2000-04-05 DK DK00921746T patent/DK1171108T3/da active
- 2000-04-05 AT AT00921746T patent/ATE241971T1/de not_active IP Right Cessation
- 2000-04-05 MX MXPA01010125A patent/MXPA01010125A/es active IP Right Grant
- 2000-04-05 ES ES00921746T patent/ES2199817T3/es not_active Expired - Lifetime
- 2000-04-05 EP EP00921746A patent/EP1171108B1/en not_active Expired - Lifetime
- 2000-04-05 PT PT00921746T patent/PT1171108E/pt unknown
- 2000-04-05 US US09/958,402 patent/US6413993B1/en not_active Expired - Fee Related
- 2000-04-05 JP JP2000610466A patent/JP2002541196A/ja active Pending
- 2000-04-05 DE DE60003175T patent/DE60003175T2/de not_active Expired - Lifetime
- 2000-04-05 CA CA002369089A patent/CA2369089A1/en not_active Abandoned
- 2000-04-05 PL PL00350987A patent/PL350987A1/xx not_active Application Discontinuation
- 2000-04-05 HU HU0200842A patent/HUP0200842A3/hu unknown
- 2000-04-05 KR KR1020017012799A patent/KR100613805B1/ko not_active IP Right Cessation
- 2000-04-05 WO PCT/US2000/009091 patent/WO2000061133A1/en active IP Right Grant
- 2000-04-05 TR TR2001/02843T patent/TR200102843T2/xx unknown
- 2000-04-05 NZ NZ514353A patent/NZ514353A/en not_active IP Right Cessation
- 2000-04-05 CN CNB008060649A patent/CN1152676C/zh not_active Expired - Fee Related
- 2000-04-05 BR BR0009676-8A patent/BR0009676A/pt not_active Application Discontinuation
-
2001
- 2001-09-24 IL IL145609A patent/IL145609A/en not_active IP Right Cessation
- 2001-10-03 NO NO20014806A patent/NO20014806L/no not_active Application Discontinuation
- 2001-10-08 ZA ZA200108254A patent/ZA200108254B/xx unknown
-
2002
- 2002-04-16 HK HK02102862A patent/HK1041638A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE60003175D1 (de) | 2003-07-10 |
CN1152676C (zh) | 2004-06-09 |
BR0009676A (pt) | 2002-09-03 |
KR20010108468A (ko) | 2001-12-07 |
DE60003175T2 (de) | 2004-04-01 |
CN1346267A (zh) | 2002-04-24 |
JP2002541196A (ja) | 2002-12-03 |
KR100613805B1 (ko) | 2006-08-18 |
NO20014806D0 (no) | 2001-10-03 |
CZ20013646A3 (cs) | 2002-06-12 |
NZ514353A (en) | 2003-10-31 |
EP1171108A1 (en) | 2002-01-16 |
ATE241971T1 (de) | 2003-06-15 |
HUP0200842A3 (en) | 2006-07-28 |
AU4202200A (en) | 2000-11-14 |
NO20014806L (no) | 2001-12-05 |
CA2369089A1 (en) | 2000-10-19 |
IL145609A0 (en) | 2002-06-30 |
EP1171108B1 (en) | 2003-06-04 |
ZA200108254B (en) | 2003-03-26 |
CZ294903B6 (cs) | 2005-04-13 |
AU758167B2 (en) | 2003-03-20 |
IL145609A (en) | 2006-04-10 |
HK1041638A1 (en) | 2002-07-19 |
PT1171108E (pt) | 2003-10-31 |
ES2199817T3 (es) | 2004-03-01 |
MXPA01010125A (es) | 2002-06-04 |
HUP0200842A2 (hu) | 2002-07-29 |
US6413993B1 (en) | 2002-07-02 |
WO2000061133A1 (en) | 2000-10-19 |
TR200102843T2 (tr) | 2002-01-21 |
PL350987A1 (en) | 2003-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9809425A (pt) | Conjugados alfa interferon-polietilenoglicol para terapia de infecção | |
GEP20053602B (en) | Aripiprazole for Oral Administration | |
WO2004096818A3 (en) | Method and compositions for identifying anti-hiv therapeutic compounds | |
LU91327I2 (fr) | Vaccin papillomavirus humain Ätypes 56,11,16,18Ü(recombinant, adsorbé) | |
BR0108210A (pt) | Vacina contra o vìrus da imunodeficiência humana | |
IL136512A0 (en) | Intravenous infusion administration set | |
DK0998287T3 (da) | Anvendelse af levobupivacain | |
AU1167602A (en) | Methods of therapy for hiv infection | |
DK1171108T3 (da) | Kombinationspræparat til behandling af malaria | |
AU2002343321A8 (en) | Isolation and purification of p. falciparum merozoite protein-142 vaccine | |
DK1007055T3 (da) | Anvendelse af amifostin | |
EE200300129A (et) | Distamütsiini alfa-halogenoakrüloüülderivaadi kasutamine | |
HK1094807A1 (en) | 1-vinylpyrrolidin-2-one/ ester copolymers | |
AU2002304480A1 (en) | Plasmodium falciparum antigens and vaccine and diagnostic uses thereof | |
AU2003223686A1 (en) | Immunogenic agent therapy using plasmapheresis or exchange transfusion | |
NO20050445L (no) | Synergistisk interaksjon mellom abacavir og alovudin | |
DK1399143T3 (da) | Anvendelsen af Acetyl L-carnitin til fremstilling af et lægemiddel til behandling af anhedoni | |
HK1039935A1 (en) | Use of (1r, 4s)-4-(6-amino-9h-purin-9-yl)-2-cyclopentene-1-methanol in hbv | |
BR8001273Y1 (pt) | suspensório médico. | |
AU2002328253A1 (en) | Pna conjugate for the treatment of diseases associated with hiv | |
UA32280A (uk) | Спосіб формування тонко-товстокишкового анастомозу бік у бік | |
UA38042A (uk) | Протифібриляторний препарат трамадол | |
PT1383563T (pt) | Métodos para o tratamento do hiv e outros vírus | |
ITMI992410A0 (it) | Vaccino per hiv | |
ZA200301175B (en) | Malaria immunogen and vaccine. |